logo
  

Asian Markets Mostly Lower As Investors Digest China Data

asiancommentary dec27 14jul19 lt

Asian stock markets are mostly lower on Monday despite the positive cues from Wall Street Friday. Investors turned cautious as they digested key economic data from China, including data that showed the country's second-quarter economic growth slowed to its weakest pace in at least 27 years. The Japanese market is closed for a holiday.

China's National Bureau of Statistics said the country's gross domestic product or GDP grew 6.2 percent in the second quarter on an annualized yearly basis, matching forecasts and down from 6.4 percent in the three months prior.

The Australian market is declining. Banks and mining stocks are weak, offsetting gains by gold miners and oil stocks.

The benchmark S&P/ASX 200 Index is losing 53.20 points or 0.79 percent to 6,643.30. The broader All Ordinaries Index is declining 50.50 points or 0.74 percent to 6,738.30. Australian stocks closed lower on Friday.

The big four banks - ANZ Banking, National Australia Bank, Westpac and Commonwealth Bank - are lower in a range of 0.6 percent to 1.0 percent.

AMP said that an interim dividend for the six months to June 30 was unlikely due to uncertainty surrounding the A$3.3 billion sale of its wealth protection business, AMP Life. The beleaguered wealth manager's shares are losing 12 percent.

The major miners are also mostly lower. BHP Group is down 0.4 percent and Rio Tinto is lower by 0.2 percent, while Fortescue Metals is advancing almost 1 percent.

Meanwhile, gold miners are higher after gold prices rose on Friday. Evolution Mining is advancing more than 1 percent and Newcrest Mining is adding 0.5 percent.

In the oil sector, Woodside Petroleum is rising 0.5 percent and Oil Search is adding 0.3 percent, while Santos is edging down 0.1 percent after crude oil prices closed flat on Friday.

In the currency market, the Australian dollar is higher against the U.S. dollar on Monday. The local currency was quoted at $0.7022, compared to $0.7000 on Friday.

Elsewhere in Asia, Shanghai, Singapore, South Korea, New Zealand, Malaysia and Hong Kong are also lower, while Indonesia and Taiwan are higher. The Japanese market is closed for the Marine Day holiday.

On Wall Street, stocks closed higher on Friday, extending the recent upward trend as the market continued to benefit from renewed optimism about the Federal Reserve lowering interest rates as soon as its next meeting later this month. Trading activity was somewhat subdued, however, as traders brace for the unofficial start of earnings season next week.

The Dow jumped 243.95 points or 0.9 percent to 27,332.03, the Nasdaq climbed 48.10 points or 0.6 percent to 8,244.14 and the S&P 500 rose 13.86 points or 0.5 percent to 3,013.77.

The major European markets closed mixed on Friday. While the French CAC 40 Index climbed by 0.4 percent, the U.K.'s FTSE 100 Index and the German DAX Index both edged down by 0.1 percent.

Crude oil futures ended flat on Friday as traders stayed largely cautious, weighing near term prospects for energy demand and supply. West Texas Intermediate WTI crude futures for August ended at $60.21 a barrel, up just a penny over previous close.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT